// App-Quantinova.ai

: Central diabetes insipidus from a patients′ perspective – from management to psychological co-morbidities and re-naming of the condition

Researchers

Presenter

  • Cihan Atila

Principal Investigators

  • Ben Loughrey

  • Aoife Garrahy

  • Bettina Winzeler

  • Julie Refardt

  • Patricia Gildroy

  • Aparna Pal

  • Malak Hamza

  • Chris Thompson

  • Joseph Verbalis

  • Steven Hunter

  • Mark Sherlock

  • Miles J Levy

  • Niki Karavitaki

  • John Newell-Price

  • John Wass

  • Mirjam Christ-Crain

Medical Centers

  • Division of Endocrinology, Diabetes, and Metabolism, University Hospital Basel, Basel, Switzerland

  • University of Bern, Department of Clinical Research, Bern, Switzerland

  • Queen’s University Belfast, Patrick G Johnston Centre for Cancer Research, Ireland

  • Churchill Hospital, Oxford Centre for Diabetes, Endocrinology and Metabolism, United Kingdom

  • Administrator and Patient Advocate for the Facebook Group: Got Diabetes Insipidus?, United States

  • University Hospital of Wales, Department of Endocrinology, Cardiff, United Kingdom

  • Royal College of Surgeons in Ireland, Dublin, Ireland

  • Beaumont Hospital Dublin, Department of Endocrinology, Ireland

  • Georgetown University Medical Center, United States

  • University of Birmingham, Institute of Metabolism and Systems Research, Birmingham, United Kingdom

  • Birmingham Health Partners, Centre for Endocrinology, Diabetes and Metabolism, United Kingdom

  • University of Sheffield Department of Oncology and Metabolism, Sheffield, UK

Locations

  • Switzerland

  • Ireland

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Neurohypophyseal diabetes insipidus

Biomarkers

  • N/A

Drug/Treatment

  • vasopressin Injection

  • Arginine hydrochloride

Outcome

  • N/A


Study Design

  • Multinational

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A